|
|
Myeloma Minute
October 11, 2012
|
|
|
10.11.12 |
 |
 |
 |
 |
|
October 11, 2012
|
 |
 |
 |
 |
 |
 |
| |
 |
Missed Today’s IMF Living Well Teleconference '10 Steps to Good Nutrition'? Listen here
ENDEAVOR Trial
6th Annual Comedy Celebration Tickets on sale now
Saturday, October 27, 2012
Be Bold, Be Bald! Join the IMF team and wear a bald cap to honor those who battle cancer.
Friday, November 2, 2012
Sacramento Regional Community Workshop
Saturday, November 3, 2012
Myeloma Center Workshop at the Mayo Clinic Scottsdale, Arizona
Saturday, November 17, 2012 |
|
 |
| Research Update: MGUS Is Not Always Trouble Free |
 |
| A recent paper in the journal Blood from the Mayo myeloma group draws attention to the fact that some patients with MGUS—Monoclonal Gammopathy of Undetermined Significance—can have renal damage from the M-component, and even complete renal failure in some instances. They propose a new name for this subtype of patient: MGRS – Monoclonal Gammopathy of Renal Significance. This is certainly helpful and draws attention to a whole range of clinical problems that can emerge from the effects of the M-component in serum and/or urine produced in MGUS patients. READ MORE |
|
|
| Cancellation of November’s FDA Advisory Committee for Pomalidomide: Bad News or Good? |
 |
| The US Food and Drug Administration (FDA) has cancelled the planned November advisory committee (ODAC) meeting for Celgene's pomalidomide application. Brian G.M. Durie, MD, Chairman and Co-founder of the IMF, considers what the cancellation might mean for patients. READ MORE |
|
|
| ‘Tom and Jerry’ Duo Brings Sense of Humor and Purpose to Advocating for Cancer Drug Parity |
 |
| A big thank you to this month’s Advocate of the Month, Tom Glass, for his enthusiasm and energy from the beginning to the end of helping his legislator in Virginia recognize the importance of cancer drug parity legislation! “I saw this as an opportunity to do something of value that I could feel good about,” said Tom, who worked alongside Jerry Walton, leader of the Southeastern Virginia Multiple Myeloma Support Group, to meet with Rep. Rigell. Hence the nickname of this dynamic duo! READ MORE |
|
|
| Weighing Bedside Manner vs. Scientific Expertise When Selecting a Doctor |
 |
| Blogger Pat Killingsworth writes that blind trust in the guidance of any physician can become problematic for a multiple myeloma patient, especially if the physician isn’t a specialist. “And even then, a second opinion is almost always a good idea whenever we find ourselves facing an important therapy crossroad.” READ MORE |
|
| |
|
| |
| Join Our Mailing List |
|
| |
|
|
|
|
|
 related articles
|
|
step 1: get the correct diagnosis
publications
back
print